Literature DB >> 16672217

The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter.

Cornelia J F de Wolf1, Rosemiek M J Cupers, Rogier M Bertina, Hans L Vos.   

Abstract

Protein S (PS) is a vitamin K-dependent plasma protein that inhibits blood coagulation by serving as a nonenzymatic cofactor for activated protein C in the protein C anticoagulant pathway. Low PS levels are a risk factor for the development of deep venous thrombosis. The regulation of PS levels through transcriptional regulation of the PS gene was investigated in this report. A minimal PS gene promoter 370 bp upstream from the translational initiation codon was sufficient for maximal promoter activity in transient transfections regardless of the cell type. A pivotal role for Sp1 in the constitutive expression of the PS gene was demonstrated through electrophoretic mobility shift assay experiments, transient expression of mutant PS promoter-reporter gene constructs, and chromatin immunoprecipitations in HepG2 cells. At least four Sp-binding sites were identified. The two sites most proximal to the translational start codon were found to be indispensable for PS promoter activity, whereas mutation of the two most distal Sp-binding sites had a negligible influence on basal promoter activity. In addition, all other major promoter-binding proteins that were found by electrophoretic mobility shift assay could be positively identified in supershift assays. We identified binding sites for the hepatocyte-specific forkhead transcription factor FOXA2, nuclear factor Y, and the cAMP-response element-binding protein/activating transcription factor family of transcription factors. Their relevance was investigated using site-directed mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672217     DOI: 10.1074/jbc.M603094200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

Review 2.  SP and KLF Transcription Factors in Digestive Physiology and Diseases.

Authors:  Chang-Kyung Kim; Ping He; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Gastroenterology       Date:  2017-03-30       Impact factor: 22.682

3.  Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex.

Authors:  Atsuo Suzuki; Naomi Sanda; Yuhri Miyawaki; Yuta Fujimori; Takayuki Yamada; Akira Takagi; Takashi Murate; Hidehiko Saito; Tetsuhito Kojima
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

4.  PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.

Authors:  A P Reiner; C L Carty; N S Jenny; C Nievergelt; M Cushman; D J Stearns-Kurosawa; S Kurosawa; L H Kuller; L A Lange
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

5.  Late onset thrombosis in a case of severe protein S deficiency due to compound heterozygosity for PROS1 mutations.

Authors:  M J Heeb; S Gandrille; J A Fernandez; J H Griffin; P F Fedullo
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

6.  Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency.

Authors:  Maria C Pintao; A A Garcia; D Borgel; M Alhenc-Gelas; C A Spek; M C H de Visser; S Gandrille; Pieter H Reitsma
Journal:  Hum Genet       Date:  2009-05-23       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.